Medicine

An early trial suggests that a drug commonly used for rheumatoid arthritis could reduce type 1 diabetics' reliance on insulin, but questions remain.

An algorithm reduced rates of antibiotics use in kids treated at Tanzanian primary care facilities without compromising their chances of getting better.

Hormone therapy for menopause might be made safer by taking statins at the same time, a study hints.

An early study in monkeys suggests that an antibody therapy could prevent fentanyl overdose.

The FDA approved two new therapies for sickle-cell disease, including the world's first-ever approved CRISPR therapy.

The announcement comes after the FDA became aware of more than 40 cases of "DRESS syndrome" linked to the seizure medications levetiracetam and clobazam.

A new vaccine, so far tested only in mice, broadly activates the immune system against a wide array of bacteria and fungi.

An early trial hints that psilocybin could be a safe and effective treatment for depressive episodes in bipolar II disorder and should be studied further.

Trans and gender-diverse people people who take testosterone face a risk of blood thickening, but the largest study to date in the U.S. suggests that this side effect is rare.

Using a CRISPR-guided technique called "base editing," scientists edited the genes of liver cells in 10 people's bodies.